touchLearning Activities
As 2024 draws to a close, we’re celebrating a fantastic year of content.
A new study has revealed that early treatment with ocrelizumab significantly reduces disease activity and long-term progression in patients with early-stage relapsing-remitting multiple sclerosis (RRMS).
In this episode, we’re joined by Bradley Love, Professor of Cognitive and Decision Sciences at UCL, ELLIS fellow, and creator of BrainGPT. We discuss how this large language model is poised to assist researchers in advancing their work.
A powerful new illustrated book, What Parkinson’s Feels Like, has been released to help build empathy and raise awareness about the lived experience of Parkinson’s disease. Created by artist Barbara Salsberg Mathews, who was diagnosed with Parkinson’s in 2020, the book translates vivid descriptions from people with Parkinson’s around the world into compelling, mixed-media illustrations.
In this insightful Q&A, Dr Lawson shares the inspirations and motivations that led him to pursue a career in neurocritical care, the challenges he faces in this demanding specialty and his vision for the future of the field.
The American Academy of Sleep Medicine (AASM) has released a new clinical practice guideline with updated recommendations for treating restless legs syndrome (RLS) in adults.
The International Neuromodulation Society (INS) recently welcomed Prof. Konstantin Slavin as its new President. A distinguished neurosurgeon with expertise in functional and stereotactic neurosurgery, Prof. Slavin brings over 30 years of experience, including notable contributions to chronic pain management, movement disorders, epilepsy, and psychiatric conditions. touchNEUROLOGY extends its best wishes for a successful presidency.
A new study published in Nature Neuroscience1 has uncovered significant insights into the progression of Alzheimer’s disease (AD), providing a new understanding of how the disease damages the brain. Funded by the National Institutes of Health (NIH) and led by researchers from the Allen Institute, this study used advanced brain mapping and genetic tools to explore the cellular-level changes that occur throughout AD. The findings reveal that Alzheimer's progresses in two distinct phases, offering potential avenues for early diagnosis and treatment strategies.
I’m an old clinician; I graduated in Medicine in 1963 at the University of Padova, Italy, and I’m proud to be on the editorial board of touchNEUROLOGY. With this in mind, I would like to express my opinions on ...
A study published in The Lancet Neurology reveals a troubling stagnation in the progress against stroke burden worldwide, with incidence rates failing to decline significantly since 2015. This analysis of the Global Burden of Disease (GBD) Study 2021 shows that the absolute numbers of strokes, related deaths and disability-adjusted life years (DALYs) have all risen considerably from 1990 to 2021, despite earlier global efforts aimed at reducing stroke mortality
In our latest Q&A, we are delighted to welcome Editorial Board member Dr David Hafler, William S. and Lois Stiles Edgerly Professor and Chairman of the Department of Neurology at Yale School of Medicine, as well as Neurologist-in-Chief at Yale-New Haven Hospital. Dr Hafler's groundbreaking work in multiple sclerosis (MS) research has helped establish the disease as an autoimmune disorder and led to the development of therapies such as natalizumab. His contributions include identifying myelin-reactive T cells, uncovering the genetic and molecular mechanisms underlying MS, and exploring the role of salt in driving autoimmune responses. A highly cited neurologist, he has received numerous awards, including the Dystel Prize, the Raymond Adams Award, and the NIH Javits Investigator Award, and is a member of the National Academy of Medicine.
In this next Q&A we welcome Prof. Dr Murat Emre. Prof. Emre studied medicine in Istanbul University and specialized in neurology in Zurich University Hospital in Zurich, Switzerland. After his training he did fellowships in movement disorders in Queen Square Hospital London and in behavioural neurology in Beth Israel Hospital, Harvard Medical School in Boston, he also worked in clinical research to develop new drugs for Parkinson's disease and Azlheimer disease. Upon his return to Turkey he founded the Movement Disorders and behavioural Neurology Unit in the Department of Neurology, İstanbul Faculty of Medicine. His main areas of interest are Parkinson!'s disease, in particular cognitive aspects/dementia and Alzheimer disease.
In our next expert Q&A we are delighted to welcome Prof. Bengt Winblad. Prof. Winblad is a prominent figure in geriatric medicine and Alzheimer's research, having served as Head of the Division of Neurogeriatrics at Karolinska Institutet and ...
In our next expert Q&A we are delighted to welcome Dr Stewart Tepper. Dr Tepper, is a distinguished figure in the field of Neurology, currently serving as the Vice President of the New England Institute for Neurology and Headache (NEINH) in Stamford, Connecticut, and as a Professor of Neurology at the Geisel School of Medicine at Dartmouth.
touchNEUROLOGY
Register Now!
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
- Save your progress for video
- Keep track of your CME credits
- Add personalised learning notes
- Receive updates from course leaders and faculty
- Be the first to hear about new and exciting interactive learning opportunities
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
